Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders

Latha Soorya; Jessica Kiarashi; Eric Hollander

doi:10.1016/j.chc.2008.06.003

Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders

Latha Soorya, Jessica Kiarashi, Eric Hollander

Research output: Contribution to journal › Review article › peer-review

56 Scopus citations

Abstract

This article provides an overview of psychopharmacological treatments for repetitive behaviors in autism spectrum disorders (ASDs) in the context of current conceptualizations of this understudied core symptom domain. The available literature on the widely used selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, fluoxetine, citalopram, escitalopram, and sertraline, are reviewed. In addition to SSRIs, research on effects of other pharmacologic interventions such as divalproex sodium, risperidone, and the neuropeptide oxytocin are presented. To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors.

Original language	English (US)
Pages (from-to)	753-771
Number of pages	19
Journal	Child and Adolescent Psychiatric Clinics of North America
Volume	17
Issue number	4
DOIs	https://doi.org/10.1016/j.chc.2008.06.003
State	Published - Oct 2008
Externally published	Yes

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Psychiatry and Mental health

Access to Document

10.1016/j.chc.2008.06.003

Cite this

@article{450f8e0f58a14bfd9d81392d1083eb97,

title = "Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders",

abstract = "This article provides an overview of psychopharmacological treatments for repetitive behaviors in autism spectrum disorders (ASDs) in the context of current conceptualizations of this understudied core symptom domain. The available literature on the widely used selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, fluoxetine, citalopram, escitalopram, and sertraline, are reviewed. In addition to SSRIs, research on effects of other pharmacologic interventions such as divalproex sodium, risperidone, and the neuropeptide oxytocin are presented. To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors.",

author = "Latha Soorya and Jessica Kiarashi and Eric Hollander",

year = "2008",

month = oct,

doi = "10.1016/j.chc.2008.06.003",

language = "English (US)",

volume = "17",

pages = "753--771",

journal = "Child and Adolescent Psychiatric Clinics of North America",

issn = "1056-4993",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders

AU - Soorya, Latha

AU - Kiarashi, Jessica

AU - Hollander, Eric

PY - 2008/10

Y1 - 2008/10

N2 - This article provides an overview of psychopharmacological treatments for repetitive behaviors in autism spectrum disorders (ASDs) in the context of current conceptualizations of this understudied core symptom domain. The available literature on the widely used selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, fluoxetine, citalopram, escitalopram, and sertraline, are reviewed. In addition to SSRIs, research on effects of other pharmacologic interventions such as divalproex sodium, risperidone, and the neuropeptide oxytocin are presented. To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors.

AB - This article provides an overview of psychopharmacological treatments for repetitive behaviors in autism spectrum disorders (ASDs) in the context of current conceptualizations of this understudied core symptom domain. The available literature on the widely used selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, fluoxetine, citalopram, escitalopram, and sertraline, are reviewed. In addition to SSRIs, research on effects of other pharmacologic interventions such as divalproex sodium, risperidone, and the neuropeptide oxytocin are presented. To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors.

UR - http://www.scopus.com/inward/record.url?scp=50449087037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50449087037&partnerID=8YFLogxK

U2 - 10.1016/j.chc.2008.06.003

DO - 10.1016/j.chc.2008.06.003

M3 - Review article

C2 - 18775368

AN - SCOPUS:50449087037

SN - 1056-4993

VL - 17

SP - 753

EP - 771

JO - Child and Adolescent Psychiatric Clinics of North America

JF - Child and Adolescent Psychiatric Clinics of North America

IS - 4

ER -

Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this